These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18295486)

  • 1. Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.
    Li J; Chen SY; Tao S; Wang H; Li JJ; Swartz S; Musial C; Hernandez AA; Flynn N; Murphy BJ; Beehler B; Dickinson KE; Giupponi L; Grover G; Seethala R; Sleph P; Slusarchyk D; Yan M; Humphreys WG; Zhang H; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1825-9. PubMed ID: 18295486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues.
    Hernández AS; Cheng PT; Musial CM; Swartz SG; George RJ; Grover G; Slusarchyk D; Seethala RK; Smith M; Dickinson K; Giupponi L; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5928-33. PubMed ID: 17869100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).
    Li J; Chen SY; Li JJ; Wang H; Hernandez AS; Tao S; Musial CM; Qu F; Swartz S; Chao ST; Flynn N; Murphy BJ; Slusarchyk DA; Seethala R; Yan M; Sleph P; Grover G; Smith MA; Beehler B; Giupponi L; Dickinson KE; Zhang H; Humphreys WG; Patel BP; Schwinden M; Stouch T; Cheng PT; Biller SA; Ewing WR; Gordon D; Robl JA; Tino JA
    J Med Chem; 2007 Nov; 50(24):5890-3. PubMed ID: 17973363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity studies of the serine-AIB dipeptide domain in 2,3-dihydroisothiazole based growth hormone secretagogues.
    Evers B; Ruehter G; Berg M; Dodge JA; Hankotius D; Hary U; Jungheim LN; Mest HJ; de la Nava EM; Mohr M; Muehl BS; Petersen S; Sommer B; Riedel-Herold G; Tebbe MJ; Thrasher KJ; Voelkers S
    Bioorg Med Chem; 2005 Dec; 13(24):6748-62. PubMed ID: 16219466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrazole based amides as growth hormone secretagogues.
    Li JJ; Wang H; Li J; Qu F; Swartz SG; Hernández AS; Biller SA; Robl JA; Tino JA; Slusarchyk D; Seethala R; Sleph P; Yan M; Grover G; Flynn N; Murphy BJ; Gordon D
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2536-9. PubMed ID: 18378446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X(7) antagonists.
    Perez-Medrano A; Donnelly-Roberts DL; Florjancic AS; Nelson DW; Li T; Namovic MT; Peddi S; Faltynek CR; Jarvis MF; Carroll WA
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3297-300. PubMed ID: 21536435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.
    Li J; Chen SY; Murphy BJ; Flynn N; Seethala R; Slusarchyk D; Yan M; Sleph P; Zhang H; Humphreys WG; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4072-4. PubMed ID: 18554903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.
    Kuduk SD; Chang RK; Dipardo RM; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5107-10. PubMed ID: 18722115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases.
    Gagnon A; Landry S; Coulombe R; Jakalian A; Guse I; Thavonekham B; Bonneau PR; Yoakim C; Simoneau B
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1199-205. PubMed ID: 19138518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
    Nelson DW; Gregg RJ; Kort ME; Perez-Medrano A; Voight EA; Wang Y; Grayson G; Namovic MT; Donnelly-Roberts DL; Niforatos W; Honore P; Jarvis MF; Faltynek CR; Carroll WA
    J Med Chem; 2006 Jun; 49(12):3659-66. PubMed ID: 16759108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted 3-((Z)-2-(4-nitrophenyl)-2-(1H-tetrazol-5-yl) vinyl)-4H-chromen-4-ones as novel anti-MRSA agents: synthesis, SAR, and in-vitro assessment.
    Diwakar SD; Bhagwat SS; Shingare MS; Gill CH
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4678-81. PubMed ID: 18650090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors.
    Al-Hourani BJ; Sharma SK; Mane JY; Tuszynski J; Baracos V; Kniess T; Suresh M; Pietzsch J; Wuest F
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1823-6. PubMed ID: 21316237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.
    Eary CT; Jones ZS; Groneberg RD; Burgess LE; Mareska DA; Drew MD; Blake JF; Laird ER; Balachari D; O'Sullivan M; Allen A; Marsh V
    Bioorg Med Chem Lett; 2007 May; 17(9):2608-13. PubMed ID: 17331716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
    Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
    Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the antiamoebic and cytotoxicity potency of novel tetrazole and triazine derivatives.
    Wani MY; Bhat AR; Azam A; Choi I; Athar F
    Eur J Med Chem; 2012 Feb; 48():313-20. PubMed ID: 22236470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of substituted benzyl tetrazoles as histamine H3 receptor antagonists.
    Davenport AJ; Stimson CC; Corsi M; Vaidya D; Glenn E; Jones TD; Bailey S; Gemkow MJ; Fritz U; Hallett DJ
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5165-9. PubMed ID: 20667729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of low molecular weight compounds with complement inhibition activity.
    Master HE; Khan SI; Poojari KA
    Bioorg Med Chem; 2005 Aug; 13(16):4891-9. PubMed ID: 15978815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.